Work

Cost-effectiveness of Lecanemab for the Treatment of Early Alzheimer’s Disease: A Canadian Societal Perspective (S23.001)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000212013

Authors: Oliver Burn, David Trueman, Kate Molloy, Adam Haynes, Kimberly Castellano, Laura Pastor, Erin Wong, Simon Rothwell, Se Ryeong Jang, Carolyn Bodnar

Institutions: Eisai Limited (Canada), Eisai (United States)

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409222605

FWCI: 0.973

Cites:

Cited by: 1

Related to: 10